FDA Clears Drug-Device Combination Matrix for Chronic Wound Care

The US Food and Drug Administration (FDA) has cleared the Omeza Collagen Matrix, a drug-device combination matrix for chronic wound care … The approval was granted through the FDA 510(k) premarket notification process. It is the first combination drug/device designed for chronic wound care … The wound care matrix is composed of hydrolyzed fish collagen infused with cod liver oil and other plant-derived oil and wax. After it is applied to a wound, the matrix is incorporated into the wound over time … read more